Literature DB >> 15974592

Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II.

Per-Ola Johansson1, Jimmy Lindberg, Michael J Blackman, Ingemar Kvarnström, Lotta Vrang, Elizabeth Hamelink, Anders Hallberg, Asa Rosenquist, Bertil Samuelsson.   

Abstract

New and potent inhibitors of the malarial aspartic proteases plasmepsin (Plm) I and II, from the deadliest malaria parasite Plasmodium falciparum, have been synthesized utilizing Suzuki coupling reactions on previously synthesized bromobenzyloxy-substituted statine-like inhibitors. The enzyme inhibition activity has been improved up to eight times by identifying P1 substituents that effectively bind to the continuous S1-S3 crevice of Plasmepsin I and II. By replacement of the bromo atom in the P1 p-bromobenzyloxy-substituted inhibitors with different aryl substituents, several inhibitors exhibiting K(i) values in the low nanomolar range for both Plm I and II have been identified. Some of these inhibitors are also effective in attenuating parasite growth in red blood cells, with the best inhibitors, compounds 2 and 4, displaying 70% and 83% inhibition, respectively, at a concentration of 5 microM. The design was partially guided by the X-ray crystal structure disclosed herein of the previously synthesized inhibitor 1 in complex with plasmepsin II.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15974592     DOI: 10.1021/jm040884n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

Review 1.  Structural studies of vacuolar plasmepsins.

Authors:  Prasenjit Bhaumik; Alla Gustchina; Alexander Wlodawer
Journal:  Biochim Biophys Acta       Date:  2011-04-20

2.  Structure-based in silico design and in vitro acaricidal activity assessment of Acacia nilotica and Psidium guajava extracts against Sarcoptes scabiei var. cuniculi.

Authors:  Afshan Khan; Muhammad Sohaib; Rooh Ullah; Imdad Hussain; Sadaf Niaz; Nosheen Malak; José de la Fuente; Adil Khan; Liliana Aguilar-Marcelino; Abdullah D Alanazi; Mourad Ben Said
Journal:  Parasitol Res       Date:  2022-08-16       Impact factor: 2.383

3.  Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.

Authors:  Peng Liu; Melissa R Marzahn; Arthur H Robbins; Hugo Gutiérrez-de-Terán; David Rodríguez; Scott H McClung; Stanley M Stevens; Charles A Yowell; John B Dame; Robert McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2009-05-19       Impact factor: 3.162

4.  Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.

Authors:  Anthony N Hodder; Brad E Sleebs; Peter E Czabotar; Michelle Gazdik; Yibin Xu; Matthew T O'Neill; Sash Lopaticki; Thomas Nebl; Tony Triglia; Brian J Smith; Kym Lowes; Justin A Boddey; Alan F Cowman
Journal:  Nat Struct Mol Biol       Date:  2015-07-27       Impact factor: 15.369

5.  Design and Synthesis of Hydroxyethylene-Based BACE-1 Inhibitors Incorporating Extended P1 Substituents.

Authors:  Veronica Sandgren; Marcus Bäck; Ingemar Kvarnström; Anders Dahlgren
Journal:  Open Med Chem J       Date:  2013-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.